<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03930563</url>
  </required_header>
  <id_info>
    <org_study_id>201812786</org_study_id>
    <nct_id>NCT03930563</nct_id>
  </id_info>
  <brief_title>Inorganic Nitrate and OSA</brief_title>
  <official_title>Acute Beetroot Juice Supplementation and Peripheral Chemoreflex Sensitivity in Patients With Obstructive Sleep Apnea</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Iowa</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Iowa</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The main purpose of this study is to determine if acute beetroot juice supplementation
      reduces peripheral chemoreflex sensitivity in patients with obstructive sleep apnea. All
      subjects will consume low-dose (BRL), higher-dose (BRH), and placebo (BRP) beetroot juice
      randomly on three independent study visits. Beetroot juice also improves blood flow thus, the
      investigators will also measure blood flow to the carotid chemoreceptors.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Four-weeks of daily beetroot juice supplementation reduces peripheral chemoreflex sensitivity
      in healthy older adults who have 'normal' responses to acute hypoxia. Patients with
      obstructive sleep apnea have exaggerated peripheral chemoreflex sensitivity. It remains
      unknown if beetroot juice supplementation reduces peripheral chemoreflex sensitivity in
      patients with obstructive sleep apnea. Additionally, increasing blood flow to the peripheral
      chemoreceptors reduces sensitivity. Given that beetroot juice improves blood flow, the
      investigators will also measure common carotid artery blood flow at rest and during hypoxia.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 12, 2019</start_date>
  <completion_date type="Anticipated">May 1, 2020</completion_date>
  <primary_completion_date type="Anticipated">May 1, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Changes in peripheral chemoreflex sensitivity</measure>
    <time_frame>Before and after consuming all supplements (within three hours)</time_frame>
    <description>The ventilatory response to acute hypoxia will be measured via pneumotachometer.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Changes in common carotid artery blood flow</measure>
    <time_frame>Before and after consuming all supplements (within three hours)</time_frame>
    <description>Blood flow through the common carotid artery before and during hypoxia measured via Doppler ultrasound</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Obstructive Sleep Apnea</condition>
  <arm_group>
    <arm_group_label>Beetroot Juice Low</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subjects will consume beetroot juice containing 250mg inorganic nitrate and 20mg nitrite dissolved in 120ml bottled water. Peripheral chemoreflex sensitivity as well as common carotid artery blood flow will be assessed before and after supplementation.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Beetroot Juice High</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subjects will consume beetroot juice containing 500mg inorganic nitrate and 40mg nitrite dissolved in 120ml bottled water. Peripheral chemoreflex sensitivity as well as common carotid artery blood flow will be assessed before and after supplementation.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Beetroot Juice Placebo</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Subjects will consume beetroot juice devoid of inorganic nitrate and nitrite dissolved in 120ml bottled water. Peripheral chemoreflex sensitivity as well as common carotid artery blood flow will be assessed before and after supplementation.</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Pre-beetroot juice supplementation</intervention_name>
    <description>Before administering beetroot juice to subjects.</description>
    <arm_group_label>Beetroot Juice High</arm_group_label>
    <arm_group_label>Beetroot Juice Low</arm_group_label>
    <arm_group_label>Beetroot Juice Placebo</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Post-beetroot juice supplementation</intervention_name>
    <description>After administering beetroot juice to subjects.</description>
    <arm_group_label>Beetroot Juice High</arm_group_label>
    <arm_group_label>Beetroot Juice Low</arm_group_label>
    <arm_group_label>Beetroot Juice Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  OSA group: patients recently diagnosed with mild-to-moderate OSA

          -  Control group: healthy individuals

        Exclusion Criteria:

          -  Diagnosis of heart disease

          -  Diagnosis of diabetes

          -  Diagnosis of any autonomic disorders

          -  Diagnosis of kidney disease

          -  Diagnosis of central sleep apnea

          -  Regular physical activity exceeding 30 minutes 3 days/week

          -  A body mass index â‰¥40 kg/m2

          -  Current or former use of a continuous positive airway pressure machine

          -  Current tobacco use

          -  Currently prescribed hormone replacement therapy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>30 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Darren P Casey, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Iowa</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Darren P Casey, PhD</last_name>
    <phone>319-384-1009</phone>
    <email>darren-casey@uiowa.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>Medical Education Building</name>
      <address>
        <city>Iowa City</city>
        <state>Iowa</state>
        <zip>52242</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Darren P Casey, Ph.D.</last_name>
      <phone>319-334-1009</phone>
      <email>darren-casey@uiowa.edu</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>June 2019</verification_date>
  <study_first_submitted>April 19, 2019</study_first_submitted>
  <study_first_submitted_qc>April 24, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">April 29, 2019</study_first_posted>
  <last_update_submitted>June 12, 2019</last_update_submitted>
  <last_update_submitted_qc>June 12, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">June 14, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Iowa</investigator_affiliation>
    <investigator_full_name>Darren P Casey</investigator_full_name>
    <investigator_title>Assistant Professor</investigator_title>
  </responsible_party>
  <keyword>inorganic nitrate</keyword>
  <keyword>blood flow</keyword>
  <keyword>Peripheral chemoreflex</keyword>
  <keyword>Common carotid artery</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sleep Apnea Syndromes</mesh_term>
    <mesh_term>Sleep Apnea, Obstructive</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

